Macrogenics (MGNX) Misses Q1 EPS by 1c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.58), $0.01 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $17.04 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Boeing wins $121 million Navy contract for P-8A upgrades
• Edgewell stock surges on report of rejected takeover bid